Merits of a New Drug Trial for ALS?
- 29 April 2005
- journal article
- letter
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 308 (5722) , 632-633
- https://doi.org/10.1126/science.308.5722.632b
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expressionNature, 2005
- Ceftriaxone in amyotrophic lateral sclerosisEuropean Journal of Neurology, 1996
- Ceftriaxone in Amyotrophic Lateral SclerosisArchives of Neurology, 1994
- Ceftriaxone is ineffective in ALSThe Italian Journal of Neurological Sciences, 1994
- Lack of improvement with ceftriaxone in motoneuron diseaseThe Lancet, 1992
- Failure of ceftriaxone for amyotrophic lateral sclerosisThe Lancet, 1992
- Improvement of patient with amyotrophic lateral sclerosis given ceftriaxoneThe Lancet, 1992